News/ News/ R&D Janssen adds Hemera’s AMD gene therapy to pipeline Richard Staines Hemera, Janssen, Johnson & Johnson, M&A, ophthalmology, R&D 0 Comment Johnson & Johnson’s pharma unit Janssen has bought rights to an investigational gene therapy for a severe form Share X Janssen adds Hemera’s AMD gene therapy to pipeline https://pharmaphorum.com/news/janssen-adds-hemeras-amd-gene-therapy-to-ophthalmology-pipeline/
Hemera, Janssen, Johnson & Johnson, M&A, ophthalmology, R&D
0 Comment
